{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T02:59:32Z","timestamp":1790909972710,"version":"4.1.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1016\/j.euroneuro.2007.11.004","type":"journal-article","created":{"date-parts":[[2008,3,6]],"date-time":"2008-03-06T23:59:30Z","timestamp":1204847970000},"page":"565-568","source":"Crossref","is-referenced-by-count":24,"title":["Sodium butyrate, an epigenetic interventional strategy, attenuates a stress-induced alteration of MK-801's pharmacologic action"],"prefix":"10.1016","volume":"18","author":[{"given":"Stephen I.","family":"Deutsch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard B.","family":"Rosse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrice D.","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brooke L.","family":"Gaskins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesssica A.","family":"Burket","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Mastropaolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2007.11.004_bib1","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/0006-8993(90)91715-S","article-title":"Profound stress-induced alterations in flurazepam's antiseizure efficacy can be attenuated","volume":"520","author":"Deutsch","year":"1990","journal-title":"Brain Res."},{"issue":"3","key":"10.1016\/j.euroneuro.2007.11.004_bib2","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0091-3057(97)90014-9","article-title":"The antiseizure efficacies of MK-801, phencyclidine, ketamine, and memantine are altered selectively by stress","volume":"58","author":"Deutsch","year":"1997","journal-title":"Pharm. Biochem. Behav."},{"key":"10.1016\/j.euroneuro.2007.11.004_bib3","unstructured":"Deutsch, S.I., Rosse, R.B., Mastropaolo, J., Long, K.D., Gaskins, B.A., in press. Epigenetic therapeutic strategies for the treatment of neuropsychiatric disorders: ready for prime time? Clinical Neuropharmacology."},{"issue":"28","key":"10.1016\/j.euroneuro.2007.11.004_bib4","doi-asserted-by":"crossref","first-page":"9418","DOI":"10.1523\/JNEUROSCI.23-28-09418.2003","article-title":"Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice","volume":"23","author":"Ferrante","year":"2003","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.euroneuro.2007.11.004_bib5","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1074\/jbc.M410210200","article-title":"Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington's disease","volume":"280","author":"Gardian","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.euroneuro.2007.11.004_bib6","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1093\/hmg\/ddh131","article-title":"Sodium butyrate ameliorates phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy","volume":"13","author":"Minamiyama","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.euroneuro.2007.11.004_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2004.10.001","article-title":"Histone deacetylase inhibitors","volume":"40","author":"Monneret","year":"2005","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.euroneuro.2007.11.004_bib8","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1111\/j.1471-4159.2005.03077.x","article-title":"Sodium phenylbutyrate prolongs survival and regulates expression of anti-apoptotic genes in transgeneic amyotrophic lateral sclerosis mice","volume":"93","author":"Ryu","year":"2005","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.euroneuro.2007.11.004_bib9","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.biopsych.2006.06.036","article-title":"Antidepressant-like effects of the histone deacetylase inhibotr, sodium butyrate, in the mouse","volume":"62","author":"Schroeder","year":"2007","journal-title":"Biol. Psychiatry"},{"issue":"24","key":"10.1016\/j.euroneuro.2007.11.004_bib10","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1056\/NEJM199506153322404","article-title":"Extended therapy with intravenous arginine butyrate in patients with \u03b2-hemoglobinopathies","volume":"332","author":"Sher","year":"1995","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.euroneuro.2007.11.004_bib11","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1073\/pnas.0510341103","article-title":"The benzamide MS-275 is a potent, long-lasting brain region-selective inhibitor of histone deacetylases","volume":"103","author":"Simonini","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.euroneuro.2007.11.004_bib12","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.schres.2004.03.001","article-title":"Schizophrenia, epigenetics and ligand-activated nuclear receptors: a framework for chromatin therapeutics","volume":"72","author":"Sharma","year":"2005","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2007.11.004_bib13","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/35099568","article-title":"Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila","volume":"413","author":"Steffan","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.euroneuro.2007.11.004_bib14","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1139\/o05-041","article-title":"Role of histone acetylation in the control of gene expression","volume":"83","author":"Verdone","year":"2005","journal-title":"Biochem. Cell. Biol."},{"issue":"18","key":"10.1016\/j.euroneuro.2007.11.004_bib15","doi-asserted-by":"crossref","first-page":"12580","DOI":"10.1074\/jbc.M511677200","article-title":"Sodium butyrate ameliorates histone hypoacetylation and neurodegenerative phenotypes in a mouse model for DRPLA","volume":"281","author":"Ying","year":"2006","journal-title":"J. Biol. Chem."}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X07002180?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X07002180?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T19:16:38Z","timestamp":1557342998000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X07002180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":15,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["S0924977X07002180"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2007.11.004","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,8]]}}}